Report Calls for FDA Nanotech Guidance (Medical Device Link)
An FDA task force on nanotechnology recommends that the agency issue guidance on what information about nanomaterials it needs to see from medical device firms and others seeking product approvals. It does not identify a need for any new laws or regulations at this time.

Zydus Cadila gets FDA nod for anti-rheumatic drug (Calcutta News)
US Food and Drug Administration (FDA) has approved Zydus Cadila's anti-rheumatoid arthritis drug, hydroxychloroquine sulfate.